Learn More
Medchemexpress LLC Tazemetostat | 1403254-99-8 | 572.74 | 25 MG

Supplier: Medchemexpress LLC 25MGHY13803R
Tazemetostat (EPZ-6438) is a potent, selective, and orally available EZH2 inhibitor. It inhibits human polycomb repressive complex 2 (PRC2)-containing wild-type EZH2 with a Ki value of 2.5 nM. It inhibits EZH2 with IC50s of 11 and 16 nM in peptide and nucleosome assays, respectively, and rat EZH2 with an IC50 of 4 nM. Tazemetostat also inhibits EZH1 with an IC50 of 392 nM. It induces apoptosis and differentiation specifically in SMARCB1-deleted MRT cells.
- Potent, selective, and orally available EZH2 inhibitor.
- Induces apoptosis and differentiation specifically in SMARCB1-deleted MRT cells.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.